Hemab Therapeutics Holdings, Inc. Common Stock (COAG)

Typically moves ±3.03% on earnings
EARNINGS ANALYTICS
search

Hemab Therapeutics Holdings, Inc. Common Stock (COAG) has only 2 recorded earnings events on file, so its post-earnings track record is limited. Its biggest recorded post-earnings gain was +3.48% (Aug 11, 2026) and its biggest decline was +2.58% (May 21, 2026).

Earnings reactions

How COAG moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

2

Avg Abs. Movement

±3.03%

Positive %

100.0%

Negative %

0.0%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
Aug 11, 2026 ☀ PRE +3.48% open_in_new
May 21, 2026 ☀ PRE +2.58% open_in_new
event

Earnings Count

2

Total earnings in dataset

trending_up

Avg Abs. Movement

±3.03%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 9 →
9
Funds holding
$59261946
Total value held
Buying
9 added · 0 reduced
Jpmorgan Chase & Co
$42328387 NEW BUY
Blackrock, Inc.
$10425186 NEW BUY
Ameriprise Financial Inc
$3009215 NEW BUY
Ubs Group Ag
$1739202 NEW BUY
Northern Trust Corp
$1487088 NEW BUY

Frequently asked about COAG earnings

How much does COAG stock move after earnings? expand_more

Over 2 reports, COAG has moved an average of ±3.03% the session after earnings, closing higher 100.0% of the time.

What was COAG's biggest post-earnings move? expand_more

COAG's largest post-earnings gain on record was +3.48% on Aug 11, 2026, and its largest decline was +2.58% on May 21, 2026.

Where can I find Hemab Therapeutics Holdings, Inc. Common Stock's SEC filings? expand_more

All of Hemab Therapeutics Holdings, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.